Summary:
In this interview, Sophia Cacciatore, Ovid Therapeutics, tells us how the biotech is building interpersonal connections with its patient populations, putting faces to names, in order to create therapeutics that could resonate in patients' lives.
For more information on Patients as Partners, visit patientsaspartnersconference.com.
